TrianglePUBLICATIONS · 30091945
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2018 Sep 20
- First author
- Hawkins DS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hawkins DS
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Tian J
- type
- Author
- name
- Arndt CAS
- type
- Author
- name
- Bomgaars L
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Hayes-Jordan A
- type
- Author
- name
- Mascarenhas L
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- McCune JS
- type
- Author
- name
- McCowage G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hawkins DS
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Tian J
- type
- Author
- name
- Arndt CAS
- type
- Author
- name
- Bomgaars L
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Hayes-Jordan A
- type
- Author
- name
- Mascarenhas L
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- McCune JS
- type
- Author
- name
- McCowage G
- type
- Author
- bibliography ids
- nci-bib-ee8da49c9675de2b7a7434d0
- book metadata
- content sha256
- 2304f7583f9ad93bbadd678092d8aba2a20fb30d52c7ab52dca1fce86ee94cc8
- document type
- citation
- dois
- 10.1200/JCO.2018.77.9694
- electronic publication date
- display
- 2018 Aug 9
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30091945
- immutable id
- pubmed:30091945@2304f7583f9ad93bbadd678092d8aba2a20fb30d52c7ab52dca1fce86ee94cc8
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 27
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2770-2777
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30091945
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- a01ad864d2b42aac4c46f899cdd91fb2f906579d83bdb8ff4da354776022f7b8
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Sep 20
- precision
- day
- year
- 2018
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Preserved source evidence · Not medical advice